myeloablative (MAC)
Showing 1 - 25 of 608
Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Hematopoietic Stem Cell Transplant (HSCT) Trial in Pittsburgh
Active, not recruiting
- Acute Myeloid Leukemia (AML)
- +2 more
- Reduced-Intensity Conditioning Regimen
- Myeloablative Conditioning Regimen
-
Pittsburgh, PennsylvaniaUPMC Children's Hospital of Pittsburgh
Jan 4, 2023
Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, MDS Trial in Tucson (Bendamustine, Cyclophosphamide)
Recruiting
- Acute Lymphoblastic Leukemia
- +12 more
-
Tucson, ArizonaThe University of Arizona Cancer Center
Dec 13, 2022
Hematologic Malignancies Trial in United States (ProHema-CB, Untreated CB)
Terminated
- Hematologic Malignancies
- ProHema-CB
- Untreated CB
-
Duarte, California
- +10 more
Nov 26, 2021
Acute Leukemia, MDS, Myeloproliferative Tumor Trial in Minneapolis (VIC- 1911)
Recruiting
- Acute Leukemia
- +3 more
- VIC- 1911
-
Minneapolis, MinnesotaMasonic Cancer Center at University of Minnesota
Apr 12, 2022
Acute Leukemia, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial
Active, not recruiting
- Acute Leukemia
- +14 more
- Busulfan
- +10 more
-
Duarte, CaliforniaCity of Hope Medical Center
Nov 18, 2022
Hematologic Malignancy Trial in Milwaukee (Tacrolimus, Methotrexate, Tocilizumab)
Active, not recruiting
- Hematologic Malignancy
- Tacrolimus
- +2 more
-
Milwaukee, WisconsinFroedtert Hospital
Jan 31, 2023
Hematologic Malignancies Trial in Milwaukee (Tildrakizumab)
Recruiting
- Hematologic Malignancies
-
Milwaukee, WisconsinFroedtert Hospital and the Medical College of Wisconsin
Sep 8, 2021
Hematological Malignancies Trial (Allogeneic T cell progenitors, cultured ex-vivo)
Not yet recruiting
- Hematological Malignancies
- Allogeneic T cell progenitors, cultured ex-vivo
- (no location specified)
Mar 2, 2023
Acute Myeloid Leukaemia Trial in Worldwide (Gemtuzumab ozogamicin, Liposomal daunorubicin, Mitoxantrone)
Recruiting
- Acute Myeloid Leukaemia
- Gemtuzumab ozogamicin
- +6 more
-
Adelaide, Australia
- +67 more
Sep 30, 2021
Primary T-cell Immunodeficiency Disorders, Common Variable Immunodeficiency, Immune System Diseases Trial in Bethesda,
Recruiting
- Primary T-cell Immunodeficiency Disorders
- +4 more
- Immunosuppression Only Conditioning -Closed with amendment L
- +4 more
-
Bethesda, Maryland
- +1 more
Jul 26, 2022
B-cell Lymphoma, Burkitt Lymphoma, Diffuse Large B Cell Lymphoma Trial in Valhalla (Polatuzumab vedotin)
Recruiting
- B-cell Lymphoma
- +8 more
- Polatuzumab vedotin
-
Valhalla, New YorkNew York Medical Center
Oct 29, 2021
Hematopoietic Stem Cell Transplantation, Acute GVHD, Acute Myeloid Leukemia Trial in United States (CD24Fc, Placebo,
Active, not recruiting
- Hematopoietic Stem Cell Transplantation
- +4 more
- CD24Fc
- +3 more
-
Duarte, California
- +3 more
Jul 19, 2021
Hematopoietic Stem Cell Transplantation, Acute GVHD, Acute Myeloid Leukemia Trial in United States (CD24Fc, Placebo,
Terminated
- Hematopoietic Stem Cell Transplantation
- +4 more
- CD24Fc
- +3 more
-
Duarte, California
- +3 more
Oct 18, 2022
Non-Hodgkin's Lymphoma, Acute Leukemia in Remission, Chronic Myeloid Leukemia Trial in Tampa (drug, radiation, procedure)
Completed
- Non-Hodgkin's Lymphoma
- +7 more
- Fludarabine
- +7 more
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Sep 14, 2021
Glottis Visualization in Different Lifting Methods
Completed
- Intubation
- Glottis Visualization
- using McGrath Video Laryngoscope
-
Zonguldak, Kozlu, TurkeyZonguldak Bülent Ecevit University
Jul 28, 2023
MAC Lung Disease Trial in United States (Epetraborole, Placebo)
Recruiting
- MAC Lung Disease
- Treatment Refractory MAC Lung Disease
- Epetraborole
- Placebo
-
Birmingham, Alabama
- +40 more
Jan 31, 2023
Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Valhalla (Gemtuzumab Ozogamicin)
Active, not recruiting
- Acute Myelogenous Leukemia
- Myelodysplastic Syndrome
- Gemtuzumab Ozogamicin
-
Valhalla, New YorkNew York Medical College
Nov 11, 2021
Mycobacterium Avium Complex Pulmonary Disease Trial (Minocycline)
Not yet recruiting
- Mycobacterium Avium Complex Pulmonary Disease
- (no location specified)
May 15, 2023
Leukemia, Myeloid, Acute Trial in Baltimore (Flotetuzumab)
Not yet recruiting
- Leukemia, Myeloid, Acute
-
Baltimore, MarylandSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Aug 16, 2022
Lymphoma, Non-Hodgkin Trial in Saint Louis (Stem cell infusion, TLI, Anti-thymocyte globulin)
Active, not recruiting
- Lymphoma, Non-Hodgkin
- Stem cell infusion
- +5 more
-
Saint Louis, MissouriWashington University
Jan 17, 2023
Allogenic Stem Cell Transplantation Trial (SAR445419)
Not yet recruiting
- Allogenic Stem Cell Transplantation
- (no location specified)
Feb 13, 2023
Glottic Opening Percentage With Miller and McGrath MAC
Completed
- Endotracheal intübation
- miller laryngoscope
- McGrath MAC videolaryngoscope
-
Zonguldak, Kozlu, TurkeyZonguldak Bülent Ecevit University
Apr 14, 2023
Intubation; Difficult or Failed, Sore-throat, Hoarseness Trial in Istanbul (Intubation using C-MAC D blade videolariyngoscope)
Completed
- Intubation; Difficult or Failed
- +2 more
- Intubation using C-MAC D blade videolariyngoscope
-
Istanbul, TurkeyYeditepe University
Aug 21, 2023
Liver Cancer Trial in Wuhan (Autologous Tumor Infiltrating Lymphocytes)
Recruiting
- Liver Cancer
- Autologous Tumor Infiltrating Lymphocytes
-
Wuhan, ChinaTongji Hospital
Oct 9, 2023